Evaluation and Validation of Virus Removal by Ultrafiltration During the Production of Diaspirin Crosslinked Haemoglobin (DCLHb)

This publication has 8 references indexed in Scilit:

• Validation of the Heat Treatment Step Used in the Production of Diaspirln Crosslinked Hemoglobin (DCLHb™) For Viral Inactivation
  Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1998
• The Risk of Transfusion-Transmitted Viral Infections
  New England Journal of Medicine, 1996
• Nanofiltration, a New Specific Virus Elimination Method Applied to High‐Purity Factor IX and Factor XI Concentrates
  Vox Sanguinis, 1994
• Size Exclusion Removal of Model Mammalian Viruses Using a Unique Membrane System, Part II: Module Qualification and Process Simulation
  Biologicals, 1993
• Theoretical analysis of pore size distribution effects on membrane transport
  Journal of Membrane Science, 1993
• Preparation and Characterization of Diaspirin Cross-Linked Hemoglobin Solutions for Preclinical Studies
  Biomaterials, Artificial Cells and Immobilization Biotechnology, 1992
• HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.
  Proceedings of the National Academy of Sciences, 1987
• Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2).
  Journal of Biological Chemistry, 1986